Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial.
about
Oral drugs in the treatment of metastatic colorectal cancer.Regorafenib with a fluoropyrimidine for metastatic colorectal cancer after progression on multiple 5-FU-containing combination therapies and regorafenib monotherapy.Update on Anti-Angiogenesis Therapy in Colorectal Cancer.An overview of experimental and investigational multikinase inhibitors for the treatment of metastatic colorectal cancer.Regorafenib in the treatment of colorectal cancer.Antiangiogenic tyrosine kinase inhibitors in colorectal cancer: is there a path to making them more effective?Emerging tyrosine kinase inhibitors for the treatment of metastatic colorectal cancer.New chemical treatment options in second-line hepatocellular carcinoma: what to do when sorafenib fails?Preclinical validation of the small molecule drug quininib as a novel therapeutic for colorectal cancer.A Comprehensive Review of Sequencing and Combination Strategies of Targeted Agents in Metastatic Colorectal Cancer.Incidence and risk of regorafenib-induced hepatotoxicity.Incidence and risk of hematologic toxicities in cancer patients treated with regorafenib.
P2860
Q30251387-BEA8B211-8083-4829-A5F0-4B14D49FD8F1Q36843760-71424181-294D-4BFF-B57E-5341ED0B8D38Q37190578-41D84B50-445C-4E73-B89A-2AD849CF202BQ38554714-F49AE7DC-26A4-494D-8B88-9CAD6C526E42Q38630817-C955C7A5-C13E-4275-9B22-ED5A97D159B9Q38672966-B56BD4C5-CB7A-4253-B60B-D2F2CC18F387Q38941928-83F5F4AD-B911-4C3A-A77B-0373BF25E955Q39010098-2B40EF8B-D8EC-46E7-8089-BC47CFA7BB19Q41462210-0ECF5804-EE59-4CB0-9D03-E8E380BD78B9Q41918758-74D19CF9-FE55-4D79-AA4A-250B3E2C0836Q45800216-993904D7-DAA1-4786-B871-5408C1683E78Q47138737-87DA69A7-9C0A-4E7C-9470-19B4DB3C8280
P2860
Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Regorafenib plus modified FOLF ...... ctal cancer: A phase II trial.
@en
Regorafenib plus modified FOLF ...... ctal cancer: A phase II trial.
@nl
type
label
Regorafenib plus modified FOLF ...... ctal cancer: A phase II trial.
@en
Regorafenib plus modified FOLF ...... ctal cancer: A phase II trial.
@nl
prefLabel
Regorafenib plus modified FOLF ...... ctal cancer: A phase II trial.
@en
Regorafenib plus modified FOLF ...... ctal cancer: A phase II trial.
@nl
P2093
P50
P1476
Regorafenib plus modified FOLF ...... ectal cancer: A phase II trial
@en
P2093
Alberto Sobrero
Andrea Wagner
Claus-Henning Köhne
Dirk Strumberg
Eric Van Cutsem
Fernando Rivera
Guillem Argilés
John Zalcberg
Julia Grunert
P304
P356
10.1016/J.EJCA.2015.02.013
P577
2015-03-25T00:00:00Z